Abiopharma

Clinical trial NCT07377344 updates: 1. start date: 2026-06-01 → 2026-09-30 2. completion date: 2028-06-01 → 2028-12-31 3. primary completion date: 2028-06-01 → 2028-09-30

Clinical trial NCT06469814 updates: 1. status: NOT_YET_RECRUITING → ENROLLING_BY_INVITATION 2. start date: 2024-09-01 → 2024-09-27 3. completion date: 2025-06-01 → 2029-07-01 4. primary completion date: 2025-06-01 → 2025-07-30

Clinical trial NCT06067230 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-30 → 2026-07-24 3. primary completion date: 2026-07-30 → 2026-07-24

Clinical trial NCT06531473 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-08-30 → 2026-04-30 3. primary completion date: 2026-08-30 → 2025-08-30 4. enrollment: 300 → 278 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04910568: status: ACTIVE_NOT_RECRUITING → RECRUITING.

Clinical trial NCT04417062 updates: 1. completion date: 2026-06-01 → 2026-12-01 2. enrollment: 63 → 49 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04201873: primary completion date: 2026-08-01 → 2025-07-01.

Clinical trial NCT06924970: primary completion date: 2026-05-01 → 2026-05-12.

Clinical trial NCT06114082 updates: 1. status: RECRUITING → COMPLETED 2. start date: 2023-04-28 → 2023-07-28 3. completion date: 2026-06-30 → 2026-07-01 4. primary completion date: 2025-12-31 → 2026-07-01 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06247995 updates: 1. completion date: 2031-09-09 → 2027-04-14 2. primary completion date: 2031-09-09 → 2027-04-14

Clinical trial NCT07433322: start date: 2026-06-01 → 2026-06-18.

Clinical trial NCT02386800: primary completion date: 2027-09-16 → 2032-04-05.

Clinical trial NCT04033445: completion date: 2027-09-29 → 2027-07-16.

Clinical trial NCT07612267 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-08-05

Clinical trial NCT05746247 updates: 1. status: ENROLLING_BY_INVITATION → COMPLETED 2. primary completion date: 2026-01-31 → 2026-06-30 3. enrollment: 750 → 610 participants 4. enrollment type: ESTIMATED → ACTUAL